Post-surgery breathing exercise management for patients and healthcare providers

Current therapeutic spirometry used after all inpatient surgeries relies on outdated mechanical devices, patient self-administration and reporting, and nursing-intensive bedside monitoring.

Airalux delivers therapeutic spirometry, redesigned:

1) Automatic adherence and performance tracking. No need for patient self-reporting or nursing bedside monitoring.

2) On-device real-time inhalation feedback and reminders, designed to make it easy for post-surgery patients to use.

We enable better therapeutic spirometry administration, monitoring, and outcomes for:

to get immediate feedback and guidance on when and how to do their post-surgery therapeutic spirometry.

patients

to check in and provide encouragement and support on their patient’s lung rehabilitation progress.

loved ones

to easily view accurate, reliable patient inhalation volume progress and adherence to administer appropriate care for patients that are non-adherent or showing concerning volume trends.

nurses

and respiratory therapists to better allocate bedside care resources for better patient outcomes.

nurse managers

to get reliable, quantitative support for earlier discharge or earlier interventions of complications both in the hospital and at home.

surgeons

to decrease risk of postoperative lung complication incidence for reduced non-reimbursed treatment costs and better bed turnover.

and hospitals systems

Funded and supported by

What we hear people ask about therapeutic spirometry…

What puts someone at risk for lung complications?

Whether a patient received a lung transplant, hip replacement, colorectal resection, or spinal fusion, their lungs will be at risk from being on anesthesia and inactivity in the hospital bed. Depending on the indication, up to ~40% of patients experience breathing issues after surgery, leading to complications like pneumonia and the need for even more medical intervention. These complications cause significant harm to patients, increase hospital stays, and make healthcare much more expensive.

What does therapeutic spirometry do?

Therapeutic spirometry (also called "incentive spirometer") is an important part of care for encouraging lung health after inpatient surgeries. When patients are stationary and were on anesthesia in the hospital, they are prone to taking shallow breaths. This can lead to a condition called atelectasis where the lungs can deflate, which lead to complications such as pneumonia, respiratory failure, and more.

Therapeutic spirometry reduces the likelihood of these complications by encouraging deep breaths that re-inflate alveoli. Patients are to take breaths with the spirometer every 10 minutes, during which they try to reach a target inhale volume set by a nurse.

Why may therapeutic spirometry “not work”?

Therapeutic spirometry suffers from low patient adherence, which make its effects limited in practice. Current therapeutic spirometers also make it very difficult to track adherence.

There are many reasons patients don't use their therapeutic spirometers: pain, confusion, forgetfulness, or a lack of motivation. Many patients also struggle to complete the exercises correctly without any help from a care provider. Between patients completing exercises incorrectly or forgetting to complete them at all, these limitations lead to preventable, post-operative pulmonary complications. 

What's the difference between Airalux and other spirometers like Aluna or Spirolink? 

Digital spirometers currently on the market are mostly diagnostic spirometers, not therapeutic spirometers. They focus on exhaled lung measurements that can help clinicians flag and diagnose lung conditions, but do not offer exercises that focus on inpatient post-surgery deep breathing. We offer features specifically targeted to breathing exercises after surgery while patients are still at the hospital that reduce the risk of post-surgery lung complications that incur treatment costs not covered by insurance reimbursements.

Airalux is developed by

  • Co-Founder, CEO

    Customer discovery. Fundraising. Firmware.

  • Co-Founder, CTO

    Data science. Clinical research. MechE. Design. SWE. The occasional electrical engineering.

  • Co-Founder

    Part-time. Software and grant writing.

  • Interns

    Axel Delakowski, University of Pennsylvania, SEAS'26, VIP-P F'24

    Thomas Liu, University of Pennsylvania, SEAS'28, VIP-P F'24

    Aditya Shah, Woodbridge Academy ‘26, F’24

    Michelle Cully, University of Pennsylvania PhD'24, VIP-P S'24

    Brandon O'Neill, University of Pennsylvania SEAS'27, VIP-P S'24

    Sophia Tang, University of Pennsylvania M&T'27, VIP-P F'23

    Wharton Consulting Groups

    Jerome Fisher M&T Innovation Fund Student Engagement S’25

    Wharton Undergraduate Healthcare Consulting F’24

    Wharton Management Consulting F’24

Penn Senior Design Founding Team (Josh Freedman, Parth Mody, Jackson Dooley, Yi-An Hsieh, Isabella Mirro)

Advisors - Business

Jeffrey Babin, MBA - Practice Professor of Engineering Entrepreneurship, Penn Engineering

Katherine Reuther, PhD - Executive Director, Penn Health Tech

Eric Sugalski, MBA - CEO, Archimedic

Andrew Tsourkas, PhD - Co-Founder, AlphaThera

Advisors - Scientific and Clinical

Matt Maltese, PhD - Co-Founder and Chief Engineer, X-Biomedical

Arshad Wani, MD - Attending Pulmonologist, Medical Director of Respiratory Care, Director of Medical ICU, University of Pennsylvania Health System

Hari Shankar, MD - Attending Pulmonoloigst, Associate Medical Director of Respiratory Care and Medical ICU, University of Pennsylvania Health System

Beth Sheridan, CNRP - Critical Care Nurse Practicioner - Trauma/Surgical ICU, University of Pennsylvania Health System

Mentors

David Meaney, PhD - Professor of Bioengineering, Penn Engineering

Sevile Mannickarottu, MS - Director of Technological Innovation and Entrepreneurship, Penn Engineering

Erin Berlew, PhD - Lecturer, Penn Engineering

John Ondik, MBA - Principal, The Ondik Group

Heather Callender-Potters - Co-Founder, PharmaJet

Sofija Jovic - CEO, ProPhase

Connect with us on LinkedIn

Spinning blue glass orb

Better patient adherence

Early complication intervention

Better recovery management

Better patient adherence • Early complication intervention • Better recovery management •

We’re recognized by…

Programs

MITRE Rise Healthcare IT Accelerator, Spring 2025

VentureWell Aspire, Fall 2024

NIH Bootcamp, Fall 2024

Pennovation Accelerator, Summer 2024

VentureWell E-Team Propel, Spring 2024

Penn/Mid-Atlantic I-Corps, Spring 2024

Penn Health-Tech Bootcamp, Spring 2024

VentureWell E-Team Pioneer, Winter 2024

Drexel Kline Law Entrepreneurship Legal Clinic, Fall 2023

Penn Law Detkin IP Clinic, Fall 2023

Penn Venture Lab VIP-Practicum, Fall 2023 and Spring 2024

Penn Venture Lab VIP-X, Summer 2023

Penn Engineering Entrepreneurship Lab, Spring 2023

Awards

Bridge Fund Award, University of Pennsylvania, Spring 2024

Miller Innovation Fellowship, University of Pennsylvania, Spring 2024

Finalist at New Venture Championships, Stu Clark Center, Spring 2024

Finalist at New Venture Competition, Baylor University, Spring 2024

Implementation Award, University of Pennsylvania, Fall 2023

Berkman Award, University of Pennsylvania, Fall 2023

1st Place in Student Design Competition, BMES/Medtronic, Fall 2023

1st place in Undergraduate Design Competition, SB3C, Summer 2023

Bioengineering Senior Design Award, University of Pennsylvania, Spring 2023